Related Experiment Video
Updated: Dec 25, 2025

Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports
Published on: November 28, 2019
Macrophage-derived SPARC Attenuates M2-mediated Pro-tumour Phenotypes
Jianwen Hu1, Yongchen Ma2, Ju Ma1
1Department of General Surgery, Peking University First Hospital, Beijing, 100034, PR China.
Secreted protein acidic and rich in cysteine (SPARC) from macrophages can suppress gastric cancer progression. SPARC overexpression in M2 macrophages reduces tumor cell proliferation, migration, and resistance to cell death.
Area of Science:
- Oncology
- Immunology
- Cancer Biology
Background:
- The tumor microenvironment significantly influences cancer progression and treatment outcomes.
- M2-type macrophages (M2) are key players in promoting tumor growth and survival.
- Secreted protein acidic and rich in cysteine (SPARC) is recognized for its anti-tumor properties in gastric cancer.
Purpose of the Study:
- To investigate the role of SPARC produced by macrophages in gastric cancer.
- To determine the effect of SPARC overexpression in M2 macrophages on gastric cancer progression.
- To explore the involvement of AKT/mTOR signaling pathways.
Main Methods:
- Analysis of SPARC expression in gastric cancer tissues.
- Investigating macrophage-derived SPARC.
- Evaluating the impact of SPARC-overexpressing M2 macrophages on cancer cell proliferation, migration, and apoptosis.
- Assessing the involvement of AKT/mTOR signaling.
Main Results:
- Macrophages were identified as a significant source of SPARC in gastric cancer.
- Overexpression of SPARC in M2 macrophages attenuated their pro-tumorigenic effects, including proliferation, migration, and anti-apoptotic activity.
- The AKT/mTOR signaling pathway was implicated in the observed malignant processes.
Conclusions:
- Macrophages are a crucial source of SPARC in the gastric cancer microenvironment.
- Enhancing SPARC levels in M2 macrophages can inhibit gastric cancer progression.
- Targeting SPARC and the AKT/mTOR pathway presents a potential therapeutic strategy for gastric cancer.
More Related Videos
09:32Drug-Induced Senescence in Liver Cells Promotes M2 Macrophage Polarization: Implications for Tyrosine Kinase Inhibitor-Associated Hepatotoxicity
Published on: October 17, 2025
06:38Macrophage Differentiation and Polarization into an M2-Like Phenotype using a Human Monocyte-Like THP-1 Leukemia Cell Line
Published on: August 2, 2021
Related Concept Videos
Abnormal Proliferation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...